Sarah Wilson
Family Medicine · Smyrna, TNNPI 1427468057
Payments from drug & device makers
Across 258 payments — averaging $17.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AbbVie$790
- AstraZeneca$310
- Abbott$258
- Pfizer$197
- Orexo US, Inc.$171
- plus $2K from 28 others
What the payments were for
- Food & beverage$4,436100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 77 | $1,163 |
| AbbVie(2 entities) | 42 | $790 |
| AstraZeneca | 11 | $310 |
| Abbott | 12 | $258 |
| Pfizer | 12 | $197 |
| Orexo US, Inc. | 9 | $171 |
| Xeris Pharmaceuticals, Inc. | 9 | $162 |
| Lilly USA, LLC | 9 | $150 |
| GSK | 11 | $150 |
| Boehringer Ingelheim | 9 | $137 |
| Otsuka America Pharmaceutical, Inc. | 8 | $129 |
| Merck | 8 | $104 |
| Astellas Pharma US Inc | 5 | $88 |
| Novartis | 4 | $73 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $58 |
| Amgen | 3 | $56 |
| Indivior Inc. | 3 | $49 |
| Gilead | 2 | $47 |
| Amarin Pharma, Inc. | 2 | $36 |
| Bayer | 2 | $35 |
| Antares Pharma, Inc. | 2 | $31 |
| Dexcom, Inc. | 2 | $27 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Sumitomo Pharma America, Inc. | 2 | $24 |
| Lundbeck LLC | 1 | $22 |
| Corcept Therapeutics | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Jazz Pharmaceuticals Inc. | 1 | $17 |
| Rhodes Pharmaceuticals L.p. | 1 | $16 |
| Inspire Medical Systems, Inc. | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Exact Sciences | 1 | $14 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
How this compares
$4,436 in reported general payments places this provider in the 80th percentile of 2,087 family medicine providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 117 | $150,601 |
| IngrezzaValbenazine Tosylate | 12 | $100,133 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 80 | $84,278 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 72 | $82,498 |
| FarxigaDapagliflozin Propanediol | 83 | $70,482 |
| RybelsusSemaglutide | 36 | $59,219 |
| MounjaroTirzepatide | 36 | $47,075 |
| EliquisApixaban | 49 | $43,818 |
| JardianceEmpagliflozin | 34 | $38,923 |
| TrulicityDulaglutide | 24 | $34,283 |
| RexultiBrexpiprazole | 21 | $31,725 |
| XareltoRivaroxaban | 16 | $22,054 |
| QuliptaAtogepant | 12 | $15,261 |
| UbrelvyUbrogepant | 12 | $14,432 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 15 | $12,999 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $1,163 | $209,820153 claims |
| AstraZenecaBreztri Aerosphere, Farxiga, Symbicort | $310 | $164,019177 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $150 | $105,744112 claims |
| Lilly USA, LLCMounjaro, Trulicity | $150 | $81,35860 claims |
| PfizerEliquis | $197 | $43,81849 claims |
| Boehringer IngelheimJardiance | $137 | $38,92334 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $129 | $31,72521 claims |
| AbbVieQulipta, Ubrelvy, Synthroid | $790 | $31,47245 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,087 family medicine providers in Tennessee.
Other family medicine in Smyrna
- Sadia DarSmyrna$50K
- Frank WadeSmyrna$33K
- Joshua HixsonSmyrna$18K
- Rickey ManningKnoxville$8.1M
- Kymberly MoyerGallatin$5.9M
- Natasha BallardChattanooga$5.7M
- Hina BudhwaniNashville$4.7M
- Paul WakefieldKnoxville$4.3M
- Emily HubbsKingsport$2.8M
- Jerry PunchKnoxville$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.